KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) EBT (2016 - 2025)

Imax's EBT history spans 16 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, EBT fell 20.66% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $63.3 million, up 67.89%, while the annual FY2025 figure was $63.3 million, 67.89% up from the prior year.
  • EBT for Q4 2025 was $6.6 million at Imax, down from $27.8 million in the prior quarter.
  • Across five years, EBT topped out at $27.8 million in Q3 2025 and bottomed at -$9.3 million in Q1 2022.
  • The 5-year median for EBT is $7.5 million (2024), against an average of $7.4 million.
  • The largest annual shift saw EBT tumbled 178.53% in 2022 before it soared 1269.41% in 2023.
  • A 5-year view of EBT shows it stood at $24.5 million in 2021, then tumbled by 75.14% to $6.1 million in 2022, then crashed by 76.04% to $1.5 million in 2023, then skyrocketed by 469.75% to $8.3 million in 2024, then fell by 20.66% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's EBT are $6.6 million (Q4 2025), $27.8 million (Q3 2025), and $13.4 million (Q2 2025).